Attorneys predict the upcoming Biden administration will try to quickly fill top leadership positions at the HHS and the FDA, and note that January’s two Senate runoff elections in Georgia could decide the fate of the Affordable Care Act before the Supreme Court does.
President-elect Joe Biden’s White House will rush to get the heads of the US Department of Health and Human Services (HHS) and the Food and Drug Administration confirmed by the Senate quickly to deal with the coronavirus pandemic, King & Spalding attorneys predict.
They also argue the fate of the Affordable Care Act may hinge on whether Democrats win two more US Senate seats in January’s Georgia runoff elections.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
